Product Information
WARFARIN SODIUM 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1063 per EA under NDC 00093172001. Its NADAC has been published 586 times since Jul 15, 2015.
FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093172001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
WARFARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040616FDA Approved
7/5/2006
TE Code
AB
On Market Since
5/12/2015
Pharmacological Classes
Price Statistics
The NADAC for WARFARIN SODIUM 10 MG TABLET has been published 586 times since Jul 15, 2015, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1063 per EA |
|---|---|
| All-time high | $0.2451 (Oct 14, 2015) |
| All-time low | $0.0947 (Sep 20, 2023) |
| 52-week high | $0.1095 |
| 52-week low | $0.0971 |
| Median price | $0.1245 |
| Average price | $0.1386 |
| Largest weekly change | +31.0% (May 17, 2017) |
| Weeks tracked | 586 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Warfarin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin K Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WARFARIN SODIUM 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1063 per EA (NDC 00093172001), effective Sep 30, 2026.
How has the price of WARFARIN SODIUM 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for WARFARIN SODIUM 10 MG TABLET has declined 56.4%. It has been tracked across 586 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 10 MG TABLET?
Since Jul 15, 2015, the NADAC for WARFARIN SODIUM 10 MG TABLET has ranged from a low of $0.0947 (Sep 20, 2023) to a high of $0.2451 (Oct 14, 2015), with a median of $0.1245 per EA.
Are there cheaper alternatives to WARFARIN SODIUM 10 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 10 MG TABLET, is $0.1053 per EA — about 1% below WARFARIN SODIUM 10 MG TABLET.
Who manufactures WARFARIN SODIUM 10 MG TABLET?
WARFARIN SODIUM 10 MG TABLET (NDC 00093172001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.